Biotech Business
The Future of Biosimilars: Key Opportunities & Emerging Therapies
Published in Drug Law Weekly, October 2nd, 2007
The Future of Biosimilars: Key opportunities & emerging therapies
http://www.reportlinker.com/p058866/Future-Biosimilars.html
Biotechnological products are continuing to exhibit substantial revenue gains, with the top 12 biologics registering sales growth of 20%in 2006, amassing a market share of $64 billion. However, the impending patent expiry of many leading products has created a number of highly attractive market opportunities for biosimilars. To exploit this significant potential, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Law Weekly
Source: Drug Law Weekly (2007-10-02)
More Articles from Drug Law Weekly
- Adverse Drug Reactions
Study results from Dartmouth College update understanding of adverse drug reactions - Drug Development
Audio: New Survey Finds Strong Public Interest in Prescription Drug Safety Issues - Drug Development
Collin County, Texas Adopts Hythiam's PROMETA Treatment Program - Drug Resistance
Study findings on drug resistance are outlined in reports from A. Kaminski and colleagues - Drug Safety
Pro-Consumer Drug Safety Reforms Agreed to in Final FDA Bill; Should End Drug Industry Gaming of Safety System - Malaria
Amid spiraling government interest, world's top 350 DNA barcode scientists meet in Taipei - More from this issue of Drug Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
